Torrent Pharmaceuticals Limited
TORNTPHARM
Rang in aandelen
#1189
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Aandeelprijs
$50.16
Marktkapitalisatie
$19.08B
Verandering (1 dag)
-0.30%
Verandering (1 jaar)
22.94%
Land
IN
Handel Torrent Pharmaceuticals Limited (TORNTPHARM)
Categorie
Healthcare
Omzet van Torrent Pharmaceuticals Limited (TORNTPHARM)
Omzet in Jun 2026 TTM: $1.72B
Volgens de laatste financiële rapporten van Torrent Pharmaceuticals Limited bedraagt de huidige omzet van het bedrijf (TTM) $1.72B. In 2024 behaalde het bedrijf een omzet van $1.29B een stijging ten opzichte van de omzet in het jaar 2023, die $1.17B bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van Torrent Pharmaceuticals Limited van 2005 tot 2026
Omzet aan het einde van elk jaar
| Jaar | Omzet | Wijzigen |
|---|---|---|
| 2026 (TTM) | $1.72B | 27.98% |
| 2025 | $1.35B | 4.66% |
| 2024 | $1.29B | 9.91% |
| 2023 | $1.17B | 4.44% |
| 2022 | $1.12B | 2.50% |
| 2021 | $1.09B | 3.76% |
| 2020 | $1.05B | -4.62% |
| 2019 | $1.10B | 20.92% |
| 2018 | $913.81M | 1.90% |
| 2017 | $896.80M | -10.88% |
| 2016 | $1.01B | 34.94% |
| 2015 | $745.76M | -3.94% |
| 2014 | $776.35M | 31.37% |
| 2013 | $590.99M | 15.51% |
| 2012 | $511.64M | 7.45% |
| 2011 | $476.15M | 11.61% |
| 2010 | $426.62M | 32.82% |
| 2009 | $321.20M | -5.13% |
| 2008 | $338.57M | 13.00% |
| 2007 | $299.62M | 37.98% |
| 2006 | $217.15M | 73.11% |
| 2005 | $125.44M | 0.00% |
Omzet van vergelijkbare bedrijven of concurrenten
| Bedrijf | Omzet | Omzetverschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 283.67% |
IN
|
